We have investigated the immunity to E colicins conferred by three group A klebicin plasmids. pPSa, which encodes klebicin A 1-P5, like pClo-DF13, confers immunity to colicin E6 on Escherichia coli K 12, whilst pP5b and pP3, which encode klebicins A2-P5 and A3-P3 respectively, both confer immunity to colicin E3. We have determined the restriction endonuclease and functional maps of the three group A klebicin plasmids. By sub-cloning and transposon mutagenesis we have investigated the relationship between the klebicin immunity and the E colicin immunity conferred by these plasmids. The colicin E6 and the klebicin A1 immunity are encoded by a single gene present on pP5a. The colicin E3 and the klebicin A2 immunity are encoded by a single gene present on pP5b. The colicin E3 and the klebicin A3 immunity are encoded by separate genes present on pP3. Recombinant pML8412, which is derived from the ColE6-CT14 plasmid and encodes colicin E6 immunity, confers klebicin Al-P5 immunity upon Klebsiella pneumoniae U NF5023. Recombinant pKC23, which is derived from the ColE3-CA38 plasmid and confers colicin E3 immunity, confers immunity to klebicin A2-P5, but not to klebicin A3-P3.
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may represent a plasmid 'caught in the act of evolution' (Lau ef al., 1984) , but the recent findings of further tandem immunity genes, against colicin E8 in the ColE6-CT14 plasmid (Lawrence, 1984) and against colicin E5 in the ColE9-J plasmid (Chak & James, 1986) . suggest that the ColE3-CA38 plasmid is far from unique.
Recently we analysed a number of producer strains in the Edmondson & Cooke (1979) klebicin typing panel and described three klebicin A plasmids, pPSa, pP5b and pP3, which encode klebicins A1-P5, A2-P5 and A3-P3 respectively (Cooper & James, 1985) . All three of these klebicins use the same cell-surface receptor to kill sensitive cells of Klebsiella pneurnoniae, but can be differentiated by the absence of cross-immunity. Klebicin Al-PS belongs to the same immunity group as cloacin DF13 (Oudega et al., 1979) . pCloDFl3 confers colicin E6 immunity on E. coli K 12 (Males & Stocker, 1982) , but it is not known whether the colicin E6 immunity is encoded by the same gene as that which confers cloacin DFI 3 immunity. Since K . pneumoniae strains are not killed by E colicins, presumably due to the absence of the btuB receptor, whilst E.
coli K 12 strains lack the aerobactin receptor (Van Tiel-Menkveld et al., 1981) and are therefore not killed by group A klebicins (Cooper & James, 1985) , it is perhaps surprising that the CloDFl3 plasmid confers immunity to an E colicin, unless the two immunities are encoded by a single gene. We have investigated the E colicin immunities conferred by the group A klebicin plasmids. We have used gene-cloning and transposon mutagenesis to determine the restriction and functional maps of the group A klebicin plasmids, and to study the relationships between their E colicin and klebicin immunity genes. Similar information has been invaluable in the study of the evolutionary relationships between the E group colicins (Watson et al., 1985 : Chak & James, 1986 .
M E T H O D S
Bacterial strains and plasmids. The strains of K. pneumoniae used in this work are listed in Table 1 . E. coli JM83 hsdR is a restriction-deficient derivative of E. coli JM83 Ara+ Lac-Pro-Thi-rpsL 680dlacZM 15. E. coli JM105 Lac-Pro-Thi-rpsL F'traD lacIqlacZM15 was supplied by Gibco-BRL. Plasmids pP5a. pP5b and pP3 were prepared from strains PC905, PC909 and PC910 respectively (Cooper & James, 1985) .
Media. Bacteria were cultured at 37 T in L broth (Miller, 1972) . The chromogenic substrate 5-bromo-bchloro-3-indolyl P-D-galactopyranoside (Xgal) was included in L agar (L broth containing 1.5'4, w/v, agar) at a final concentration of 20 pg ml-I to detect recombinant plasmids. Ampicillin (Ap) was included in all media, at a final concentration of 100 pg ml-' for the growth of all E. coli K 12 strains which carried recombinant plasmids, and at a final concentration of 200 pg ml-I for all Klebsiella strains which carried recombinant plasmids.
Klebicin production and immunity tests. Klebicin production was determined by stab tests (Ozeki et al., 1962) . using K. pneumoniae UNF5023 as the sensitive indicator strain. Klebicin immunity was determined by overlaying stabs of PC905, PC909 and PC910 with lawns of K. pneumoniae UNF5023 carrying the test plasmid. E colicin immunity was determined by streaking cultures of E. coli JM83 hsdR carrying the test plasmid on LB agar plates spread with E colicin extracts prepared as described previously (Chak & James, 1984) . Each test was done on at least six isolates from each test culture to determine the phenotype encoded by each recombinant plasmid. Plasmid isolation, rcwriction, ligation, transformation and electrophoresis. All plasmids were prepared by a modification of the method of Birnboim & Doly (1979) . The methods for restriction, ligation, transformation and electrophoresis of plasmid D N A have been described previously (Chak & James. 1984) . Cia1 linker was obtained from Gibco-BRL and was used as described previously (Maniatis et al., 1982) .
Co-rrcmsf~rniutiori. In the absence of a good positive selection for the transformation of the three group A klebicin plasmids into E. coli, we used a co-transformation procedure. The native group A klebicin plasmids were transferred into E. coli JM83 hsdR by transforming with a mixture of pUC8 vector and the native klebicin plasmid in a ratioof 1 : 10. The relative DNA concentrations of the respective plasmids were estimated by a comparison of their band intensities after agarose gel electrophoresis. Transformants were selected on Ap-containing plates and were then screened for. klebicin production.
Transposon niutagenesis. This was done with TnfUUU as described previously (Chak & James, 1984) . The insertion sites of TnfUUU were determined by restriction with EcuRI, BaniHI and Hind111 (Guyer, 1978) .
Electrophoresis (?f'klehicim. Cultures of K. pncwnoniae U NF5023 carrying appropriate plasmids were grown in L broth to an OD55, of 0.2 before the addition of MC (0.5 pg ml-') to half of each culture to induce the synthesis of klebicins. After 2 h further incubation. 1 ml of each culture was removed and the cells were recovered by centrifugation. The cell pellet was resuspended in 100 pI electrophoresis sample buffer, heated to 100 "C for 5 min and then centrifuged again. Portions (25 pl)of the total cell proteins were then analysed by SDS-PAGE (Laemmli, 1970) in lo", (w,!v) gels using standard proteins as molecular mass markers. This experiment was repeated twice with identical results. Hj*hridization. Specific fragments to be used as hybridization probes were isolated from low-melting-point agarose and labelled with [J5S]CTP (Amersham) using a Multiprime kit (Amersham), following the supplier's instructions. Restricted plasmids were tested for their hybridization with the probes after Southern blotting onto nitrocellulose filters. Hybridization was done at 68 'C for 16 h in the absence of formamide as described by Maniatis et al. (1982) .
R E S U L T S A N D DISCUSSION

E colicin immunitic~s conftvrcd hj. A klehicin plasniids
The native group A klebicin plasmids were transferred to E . coli JM83 hsdR by cotransformation with p U f 8 . Representative ApK colonies which carried pUC8, with either pPSa, pPSb, pP3 or no plasmid, were then tested for their immunity to E colicins (Table 2 ). E. coli JM83 hsdR which had been transformed with pJN73, a CloDF13 plasmid which carries Tn901 inserted in a non-essential region of the plasmid (Andreoli et al., 1978) , was included as a control. The results clearly show that pP5a. like CloDFl3, confers colicin E6 immunity, whilst the pP5b and the pP3 plasmids confer colicin E3 immunity. In order to study the relationship between the respective klebicin and colicin immunity phenotypes conferred by the group A klebicin plasmids we used molecular cloning techniques and transposon mutagenesis.
Clonirig of' the kl&ic.iti A 1-P.5 plusniiii Preliminary restriction mapping of native pP5a indicated considerable similarity with pCloDF13 (data not shown). We cloned SdI-restricted pP5a DNA into the SalI site of vector pUC8 and then transformed E. coli JM83 hsdR to Ap resistance. The white transformant colonies on Xgal/Ap plates were tested for klebicin production. Recombinant pRJ 1 I9 was isolated from a klebicin-encoding transformant but this plasmid, which contained the whole 9.8 kb pP5a plasmid, was unstable. We have been unable to construct a stable recombinant plasmid which produces klebicin Al-P5. Restriction of pP5a DNA with BamHI yields two fragmentsof 8.3 kb and 1.5 kb. Ligation of BumHI-restricted pP5a DNA with BumHI-restricted pUC8, and subsequent transformation of E . coli JM83 hsdR to ApR and colicin E6 immunity, yielded transformant colonies which carried pRJ 118. On testing, this recombinant plasmid did not encode klebicin production. Restriction of pRJ 118 with BamHI yielded fragments of 8.3 kb and 2.7 kb. These results indicate that the klebicin A1-P5 structural gene is at least partially located within the 1.5 kb BamHI fragment of pP5a. A similar location has previously been reported for the cloacin DF13 structural gene on the Clo-DF13 plasmid (Hakkaart et al., 1981) . A restriction map of pRJ 1 18 is shown in Fig. 1. pRJ 1 18 was 
and a representative colony was tested to confirm that klebicin A1-P5 immunity was encoded by this plasmid. K . pneumoniae cultures carrying p R J l l 8 were, however, sensitive to klebicins A2-P5 and A3-P3.
In an attempt to localize the klebicin A I -P5 immunity gene and the colicin E6 immunity gene, we constructed a series of sub-clones of p R J l l 8 (Fig. 1) . The phenotypes conferred by recombinant plasmids pRJ15O and pRJ153 suggest that the colicin E6 and the klebicin A1 immunity genes are located in the 2.2 kb SmuI-BamHI fragment of pP5a. This was confirmed by deletion of the 2.1 kb BaniHI-SmaI fragment of pRJ 150 by restriction with BamHI and SmaI and subsequent religation. The resulting plasmid, pRJ262, conferred immunity to colicin E6 upon E. coli JM105. During the construction of pRJ262 from pRJ150, the orientation of the insert fragment is reversed with respect to the vector lac promoter. This required the use of E. coli JM105 as a host strain for transformation in order to repress the lac promoter of the vector, since we had previously observed that the 2.2 kb SrnaI-BamHI fragment could not be cloned in The precise localization of the colicin E6 imm gene was determined by deletion of the 300 bp ClaI fragment of pRJ262, from the single Chi site in the insert fragment to a CIuI site in the vector, introduced by inserting a CluI linker into the HincII site of the vector. The resulting plasmid pRJ263 did not confer E6 immunity upon E. coli JM105, although it still exhibited the IPTGs phenotype, indicating that the vector promoter was still transcribing through the insert fragment. When transformed into K . pneumoniue UNF5023, again in the presence of glucose, pRJ263 did not confer klebicin A 1 immunity. This result is in agreement with the localization of the cloacin DF13 immunity gene (Hakkaart et d., 1981) and confirms that the colicin E6 immunity and the klebicin A1 immunity genes are identical.
Cloning of the klebicin A2-P.5 plasmid Restriction mapping of the native 7.5 kb pP5b plasmid indicated the presence of a single BglII site (data not shown). We cloned BglII-restricted pP5b DNA into the BamHI site of vector pUC8 and then transformed E. coli JM83 hsdR to ApR. Plasmid pRJ132 was isolated from a recombinant clone which produced klebicin A2-P5 and conferred immunity to colicin €3. After transfer to K . pneumoniae 1JNF5023 by transformation, plasmid pRJ 132 conzerred klebicin A2-P5 immunity. Restriction mapping confirmed that this plasmid consisted of the whole pP5b plasmid cloned into the BamHI site of the vector. In an attempt to locate the klebicin A2-P5 structural gene and the two immunity genes, we constructed a series of sub-clones of plasmid pRJ132 (Fig. 2) . The phenotype conferred by plasmid pRJ155 localizes the three genes of interest to the 4.3 kb XhoI-BglII fragment of pP5b. Klebicin production was inactivated by deletion of the 1.5 kb BumHI fragment of pRJ155. The resulting plasmid, pRJ159, still conferred klebicin A2-P5 and colicin E3 immunity. The phenotypes conferred by plasmids pRJ164 and pRJ244 localize the two immunity genes to the 600 bp SphI-BurnHI fragment of pPSb. TnZOOO mutagenesis of pRJ155 confirmed that the two immunity genes must have a separate promoter(s) to the klebicin structural gene as four independent transposon inserts located at 1.5 kb, 1.7 kb, 1.9 kb and 2.4 kb all inactivated the klebicin structural gene but did not affect either immunity phenotype (Fig. 2) . This identifies a minimum region coding for the klebicin A2-P5 gene of 900 bp, sufficient to code for a protein of 33 kDa. Using plasmid pRJ 164, all TnZOOO inserts which inactivated the colicin E3 immunity phenotype also inactivated klebicin A2-P5 immunity. The site of insertion of three of these inserts in pRJ164 is shown in Fig. 2 . In a modified TnZOOO mutagenesis experiment we transformed K . pneumoniue UNF5023 with plasmid DNA prepared from 36 randomly selected transconjugant E. coli colonies. Single, representative transformant colonies were grown up in LB containing Ap and then tested for sensitivity to klebicin A2-P5. The transposon insertion sites of six klebicin A2 sensitive transformants were all located in the right-hand 350 bp of the 950 bp XhoI-BumHI fragment of pRJ164. After transformation of these six plasmids into E. coli JM83 hsdR, all of the resulting transformants were colicin E3 sensitive. This result strongly suggests that the colicin E3imm gene and the klebicin A2imm gene are identical.
Cloning f ' the klebicin A3-P 3 plasmid Restriction mapping of the native 12.5 kb pP3 plasmid indicated the presence of two HindIII sites, yielding fragments of 7.0 and 5.5 kb. We cloned HindIII-restricted pP3 D N A into the HindIII site of pUC 18 and transformed E. coli JM83 hsdR to ApR and colicin E3R. pRJ 157 was isolated from a recombinant clone which produced klebicin A3-P3 and was immune to colicin E3. After transfer to K . pneumoniue UNF5023, this plasmid conferred immunity to klebicin A3- E colicin immunity genes of klehicin plasmids Table 3 . Klehicin imnrunities conjerred b j E colicin immunitj. genes P3, but not to klebicin A 1-P5 or to klebicin A2-P5. Restriction mapping confirmed that pRJ 157 consisted of the 7 kb HindIII fragment of pP3 cloned into the HindIII site of pUC18. In an attempt to localize the klebicin A3-P3 structural gene and the two immunity genes we constructed a series of sub-clones of pRJ157 (Fig. 3) . The phenotype conferred by plasmids pRJ246 and pRJ250 indicates that the E3imm gene must lie in the 1.35 kb EcoRI-Pstl fragment of pRJ246. The phenotype conferred by pRJ253 shows that the E3imm gene is distinct from the klebicin A3imm gene and that the E3imrn gene is cut by EcoRI. TnlOOO inserts located at 1.9 kb, 2.6 kb, 2.95 kb and 3-15 kb in pRJ157 inactivated klebicin A3-P3 production (Fig. 3 ). This identifies a region of 1.25 kb as the minimum size of the klebicin A3-P3 structural gene, sufficient to encode a protein of 46 kDa. The TnZOOO inserts located at 2-6 kb, 2.95 kb and 3.15 kb did not affect klebicin A3 or colicin E3 immunity; however, the insert at 1.9 kb abolished klebicin A3 immunity but not colicin E3 immunity. This suggests that the klebicin A3 immunity gene promoter is located between 1.9 kb and 2.6 kb. This is in agreement with the phenotype conferred by pRJ246, in which the klebicin A3 immunity gene promoter has presumably been deleted. Transposon inserts located at 3.8 kb and 4.3 kb in pRJ246 inactivated the E3imm gene. Although we have no direct evidence, by analogy with the genetic organization of other bacteriocins it may be reasonable to assume that the A3irnrn gene is located between the klebicin structural gene and the E3imm gene.
Klebicin immunity conferred by E colicin plasmids In view of the E colicin immunity conferred by the A klebicin plasmids and the probability, in the case of the pP5a and the pP5b plasmids, that the colicin and klebicin immunity genes are identical, we investigated the klebicin immunity conferred by recombinant plasmids which carry defined regions of E colicin plasmids. Recombinant pML8412 consists of the 1.2 kb ClaIEcoRI fragment of pColE6-CT14 cloned into pBR322 restricted with ClaI and EcoRI (Lawrence, 1984) . This plasmid confers colicin €6 immunity on E. coli K 12 and klebicin A 1-P5 immunity on K. pneumoniae UNF5023 (Table 3) , and thus supports our findings that these two immunity proteins are encoded by a single gene. pKC23 consists of the 1.0 kb EcoRI-CluI fragment of pColE3-CA38 cloned into pBR322 restricted with EcoRI and ClaI (Chak & James, 1984) . This plasmid confers colicin E3 immunity on E. coli K 12 and klebicin A2-P5 immunity on K. pneumoniae UNF5023; however, pKC23 does not confer immunity to klebicin A3-P3. Inspection of the nucleotide sequence of the 1 kb Clul-EcoRI fragment of pColE3-CA38 has shown the presence of a second open reading frame (ORF) at the 3' end of the colicin E3 structural gene. This ORF directs the synthesis of an 1 1 kDa protein in vitro (Mock eta/., 1983) . To exclude the possibility that it is this O R F which encodes the klebicin A2 immunity protein we examined the phenotype conferred by p3294, which is a Ba13 1 deletion from the EcoRI site of pLAX4, a plasmid identical to pKC23 (Mock et al., 1983 (Mock et al., , 1984 . p3294, which has lost the E3imm gene as a result of the Bu13 1 deletion and still directs the-s'ynthesis of the 1 1 kDa protein in vitro (Mock et ul., 1983) , does not confer immunity to klebicin A2-P5 (Table 3) . These results strongly suggest that the E3imm gene of pColE3-CA38 and the klebA2imm gene of pP5b are capable of conferring immunity to both colicin E3 and klebicin A2-PS. Since immunity is very specific, this implies that the killing activities of the two bacteriocins are very similar, if not 2260 Fig. 4 SDS-PAGE of klebicins. The migration of the molecular mass markers used and their molecular masses (kDa) are indicated by lines on the left-hand side. The band corresponding to the klebicins is indicated by an arrow. Total cell proteins were prepared from cultures of K. pneumoniae UNF5023 carrying pRJ157 (lanes 1 and 2); pRJ157::TnlOOO (lanes 3 and 4); pRJ155 (lanes 5 and 6); pRJ155 : : TnlOa) (lanes 7 and 8); pJN73 (lanes 9 and 10); and no plasmid (lanes 11 and 12). In the lefthand lane of each pair the culture was grown in the presence of MC (0.5 pg ml-'); in the right-hand lane of each pair the culture was grown in the absence of MC.
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identical. Nucleotide sequencing of the klebicin A2-P5 structural gene and the immunity gene would allow a detailed comparison with that published previously for colicin E3 (Mock et al., 1983; Masaki & Ohta, 1985) . Recombinant plasmids which carried the colicin E5, colicin E8 or colicin E9 immunity gene did not confer any immunity to the group A klebicins (data not shown).
Transfer of the btuB gene to Klebsiella K . pneumoniae strains are insensitive to E colicins, presumably because they lack the btuB receptor. The btuB gene of E. coli K12 has been cloned in pBR322, yielding the recombinant pKH3-8 (Heller et at., 1985) . When K. pneumoniae UNF5023 was transformed with pKH3-8 DNA all ApR transformants tested, unlike K. pneumoniae UNF5023 itself, were sensitive to colicins E3, E6 and E8. They were also sensitive to phage BF23, which uses the btuB gene product of E. coli as a receptor (Buxton, 1971) . This implies that, with the exception of the btuB receptor, K. pneurnoniae cells contain all the machinery for the uptake of E colicins and BF23 bacteriophages.
Homology between klebicin A plasmids A comparison of the restriction maps of the three klebicin A plasmids reveals few common sites, with the exception of the 1.5 kb BamHI fragment of pP5a and pPSb, both of which include at least part of the coding sequence of their respective klebicin structural genes. This is in contrast to the considerable restriction site homology observed between members of the E group of colicin plasmids (Watson et al., 1985; Chak & James, 1986) , and prevents any alignment of their restriction maps based upon common restriction sites. The molecular masses of klebicins A2-P5 and A3-P3 appear to be almost identical to that of cloacin DF13 as judged by SDS-PAGE (Fig. 4) . The identification of the bands corresponding to klebicins A2-P5 and A3-P3 was assisted by a comparison of the total cell proteins of cultures of K. pneumoniae UNF5023 carrying klebicin-encoding plasmids, after growth in the presence and absence of MC. The bands which corresponded to the presumptive klebicins A2-P5 and A3-P3 were missing from total cell proteins derived from cultures carrying plasmids pRJ 155 and pRJ 157 with TniOOO inserts which inactivate the respective klebicin structural genes.
In order to investigate further the homology between klebicins A2-P5 and A3-P3 we did some preliminary experiments with a hybridization probe consisting of the 1-5 kb BamHI fragment of pRJ155. This fragment, which must encode a considerable part of the klebicin A2-P5 structural gene but does not include the E3imm gene (Fig. 2) , hybridized to the 5.7 kb BamHI fragment of pRJ157 but did not hybridize with pUC18 or pUC19 (data not shown). The 5.7 kb BamHI fragment of pRJ 157, which consists of the 3 kb HindIII-BamHI fragment of pRJ 157 plus the 2.7 kb vector (Fig. 3) , includes a significant part of the klebicin A3-P3 structural gene. The 1.5 kb BamHI probe also hybridized with both PstI fragments of pRJ157. These results imply considerable homology between the klebicin A2-P5 and the klebicin A3-P3 structural genes. A detailed comparison of the nucleotide sequences of these three plasmids will be invaluable in elucidating their evolutionary relatedness. It will be particularly interesting to compare the nucleotide sequence of the E3imm gene of pP3 with that of the klebA3-P3imm gene of the same plasmid to look for signs of divergent evolution after a gene duplication event. An understanding of the genetic organization and regulation of the three klebicin operons will also be of value in obtaining high titre extracts of these klebicins for use in a klebicin typing scheme (Cooper & James, 1985) .
